How Has the Kidney Transplant Market Size Evolved in Recent Years?
The kidney transplant market has seen considerable growth due to a variety of factors.
•In the past several years, there has been a consistent growth in the kidney transplant market. The market value, presently forecasted to rise from $6.15 billion in 2024 to $6.44 billion in 2025, is projected to escalate at a compound annual growth rate (CAGR) of 4.6%.
Factors contributing to this upward trend during the historic period include progress in research and clinical trials, improved patient instruction and assistance, advanced diagnostic methods, enlightenment in post-transplantation care, as well as developments in immunosuppressive treatments.
What are the Market Size and Expected Growth Rates for the Kidney Transplant Market?
The kidney transplant market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for kidney transplants is predicted to experience robust expansion in the forthcoming years. The projection is a surge to "$7.89 billion by 2029, representing a compound annual growth rate (CAGR) of 5.2%.
The growth expected in this forecast period can be credited to factors such as the rise in the demand for transplant procedures, the advancement in immunomodulatory treatments, growing pool of living donors, reduction of patient wait times, and the use of telemedicine for pre-transplant assessments. Key trends anticipated in this forecast period encompass patient-focused care models, advancements in xenotransplantation research, improved monitoring for organ rejection, the application of telemedicine for post-transplant care, alongside wider availability for transplant procedures.
Which Drivers Are Accelerating Growth In The Kidney Transplant Market?
The escalation in the number of kidney diseases and kidney failure instances is set to spur the expansion of the kidney transplant market in the future. Kidney diseases and failure occur when the kidneys lose their ability to maintain biochemical equilibrium or discharge waste and additional fluids from the bloodstream. In such a scenario, a kidney transplant is necessary to recover kidney function and tackle the root issues triggering kidney failure. For example, data from the American Kidney Fund, a not-for-profit organization based in the US, highlighted that 37 million Americans were afflicted by kidney illnesses in 2023. As such, the escalating number of kidney diseases and instances of kidney failure are fuelling the kidney transplant industry's growth.
What Are The Core Segments Of The Global Kidney Transplant Market?
The kidney transplant market covered in this report is segmented –
1) By Transplant Type: Deceased-Donor Kidney Transplant, Living-Donor Kidney Transplant, Expanded Criteria Donor
2) By Age Group: Adult, Pediatrics
3) By Application: Drug Delivery, Capsule Endoscopy, Patient Monitoring
4) By End-User: Transplant Centers, Hospitals, Academic And Research Institutes
Subsegments:
1) By Deceased-Donor Kidney Transplant: Standard Criteria Donor, Extended Criteria Donor
2) By Living-Donor Kidney Transplant: Related Living Donor, Unrelated Living Donor, Paired Kidney Exchange
3) By Expanded Criteria Donor: Older Donors, Donors With Hypertension, Donors With Kidney Disease History
Pre-Book The Kidney Transplant Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Trends Are Reshaping The Kidney Transplant Market Size?
Innovations in kidney transplant procedures are becoming a trending factor within the kidney transplant market. To maintain their competitive edge, firms within this market are committed to developing novel kidney transplant solutions. For example, Stanford Medicine, a healthcare provider based in the United States, launched a new procedure known as DISOT in June 2022. This procedure, which involves dual immune/solid organ transplant for pediatric kidney transplantation, transfers the immune system of the donor to the recipient before conducting the kidney transplant. As a result, the continual need for immunosuppressive drugs is eliminated. This progress provides substantial benefits for patients, as they can avoid the severe long-term effects linked to immunosuppressive drugs, such as an elevated risk for cancer, diabetes, infections, and high blood pressure.
Who Are the Key Players in the Kidney Transplant Market?
Major companies operating in the kidney transplant market include:
• Pfizer Inc.
• Novartis AG
• B. Braun Melsungen AG
• Fresenius Medical Care AG & Co.
• Medtronic Plc.
• TransMedics Inc.
• Preservation Solution Inc.
• Organ Recovery Systems Inc.
• Transonic Systems Inc.
• DaVita Inc.
• Glycorex Transplantation AB
• Astellas Pharma Inc.
• Veloxis Pharmaceuticals A/s
• Immucor Inc.
• Penn Medicine
• Sanofi S.A
• Amgen Inc.
• Amyndas Pharmaceuticals
• Abbvie Inc.
• Teva Pharmaceuticals Ltd.
• BiolifeSolutions
• Bristol-Myers Squibb Company
• CareDx Inc.
• CSL Behring
• Grifols S.A.
• Kedrion Biopharma Inc.
What are the Regional Insights into the Kidney Transplant Market?
North America was the largest region in the kidney transplant market in 2024.Europe is expected to be the fastest-growing region in the global kidney transplant market report during the forecast period. The regions covered in the kidney transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
